欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Aldose Reductase

Aldose Reductase

货号 产品名 CAS号 信息
CSN36334 Zopolrestat 110703-94-1 Zopolrestat is a aldose reductase inhibitor.
CSN12110 Tolrestat 82964-04-3 Tolrestat is a potent, orally active aldose reductase inhibitor with IC50 value of 35 nM.
CSN27705 Ponalrestat 72702-95-5 Statil is a selective and noncompetitive aldose reductase 2 inhibitor with Ki value of 7.7nM.
CSN17888 Ranirestat 147254-64-6 Ranirestat is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy.
CSN16506 (E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one 961-29-5 Isoliquiritigenin is a licorice chalconoid, a type of natural phenols, and a sirtuin-activating compound.
CSN21685 Imirestat 89391-50-4 Imirestat is an inhibitor of aldose reductase which is used for the treatment of diabetes.
CSN22130 Fidarestat 136087-85-9 Fidarestat is an inhibitor of aldose reductase, with IC50s of 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10 and V301L AKR1B10, respectively; Fidarestat has the potential to treat diabetic disease.
CSN12976 2-((Z)-5-((E)-2-Methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid 82159-09-9 Epalrestat is an aldose reductase inhibitor with IC50 of 72 nM, and used for the treatment of diabetic neuropathy.
CSN14844 Dehydroglyasperin D 517885-72-2 Dehydroglyasperin D, a natural product isolated and purified from the roots of Glycyrrhiza uralensis with anti-obesity, antioxidant, anti-aldose reductase, anticancer, anti-inflammator and strong ferric reducing activities, inhibits the proliferation of HT-29 human colorectal cancer cells through direct interaction with phosphatidylinositol 3-kinase, mediates suppression of both COX-2 expression and the MLK3 signalling pathway through direct binding and inhibition of MLK3, effectively scavenges DPPH, ABTS(+), and singlet oxygen radicals.
CSN25218 AT-007   2170729-29-8 AT-007 is a central nervous system (CNS) penetrant Aldose Reductase inhibitor (ARI) in Phase 1/2 development for treatment of Galactosemia.
CSN18314 Sodium 2-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetate 51876-97-2 Alrestatin sodium is an inhibitor of aldose reductase, an enzyme involved in the pathogenesis of complications of diabetes mellitus, including diabetic neuropathy.
CSN10270 Alrestatin 51411-04-2 Alrestatin is an inhibitor of aldose reductase, an enzyme involved in the pathogenesis of complications of diabetes mellitus, including diabetic neuropathy.
CSN17745 Caficrestat 1355612-71-3 Aldose reductase-IN-1 is an inhibitor of aldose reductase with IC50 of 28.9 pM.
CSN23670 AKR1C1-IN-1 4906-68-7 3-bromo-5-phenyl Salicylic Acid is a cell-permeable salicylic acid compound that acts as a highly potent, active-site directed and substrate competitive AKR1C1 inhibitor (Ki = 4 nM) with moderate to excellent selectivity over AKR1C2, AKR1C3 and AKR1C4 (Ki = 0.087, 4.2 and 18.2 µM, respectively).
<< PREV 1 NEXT >>
联系
我们